PF07104091
CAS No. 2460249-19-6
PF07104091( PF-07104091 )
Catalog No. M28851 CAS No. 2460249-19-6
PF-07104091 inhibits CDK2, which may lead to cell cycle arrest, induce apoptosis and inhibit tumor cell proliferation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 915 | In Stock |
|
| 2MG | 519 | In Stock |
|
| 5MG | 824 | In Stock |
|
| 10MG | 1207 | In Stock |
|
| 25MG | 1796 | In Stock |
|
| 50MG | 2372 | In Stock |
|
| 100MG | 3190 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePF07104091
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-07104091 inhibits CDK2, which may lead to cell cycle arrest, induce apoptosis and inhibit tumor cell proliferation.
-
DescriptionPF-07104091 inhibits CDK2, which may lead to cell cycle arrest, induce apoptosis and inhibit tumor cell proliferation.
-
In Vitro——
-
In Vivo——
-
SynonymsPF-07104091
-
PathwayAngiogenesis
-
TargetCDK
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2460249-19-6
-
Formula Weight404.46
-
Molecular FormulaC19H28N6O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C(=O)C1=CC(COC)=NN1C)C2=CC(=NN2)[C@@H]3C[C@H](OC(NC(C)C)=O)CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yamaguchi T, et al. Determination of 7-chloro-3-(4-methyl-1-piperazinyl)-4h-1,2,4-benzothiadiazine-1,1-dioxide (DU-717) in plasma using electron-capture gas chromatography. J Chromatogr. 1978 Oct 11;160(1):181-90.
molnova catalog
related products
-
Abemaciclib metaboli...
Abemaciclib metabolite M20 is an active metabolite of Abemaciclib.
-
Cdc7 inhibitor 7c
A highly potent, selective and time-dependent Cdc7 kinase inhibitor with IC50 of 0.7 nM with slow dissociation property, with 200-fold and >14,000-fold selectivity over CDK2 and ROCK1, respectively.
-
BS-194
BS-194 is a potent, selective, orally bioactive CDK2 inhibitor with IC50 of 2.4 nM, displays 140-fold selectivity over CDK7 (IC50=378 nM); weakly inhibits CDK1, CDK5, CDK7, and CDK9 with IC50 of 30, 30, 250, and 90 nM.
Cart
sales@molnova.com